TCE Specialist CytoCares Makes Inroads Into Autoimmune Space

autoimmune disease
CytoCares aims to repurpose its T-cell engagers for the treatment of autoimmune diseases from cancers. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from Scrip